sizofiran has been researched along with Cancer of Head in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukase, S; Kimura, Y; Takeda, K; Tojima, H | 1 |
| Hashimoto, J; Kakuta, H; Kano, Y | 1 |
2 trial(s) available for sizofiran and Cancer of Head
| Article | Year |
|---|---|
Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer.
Topics: Adult; Aged; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Drug Evaluation; Female; Head and Neck Neoplasms; Humans; Injections, Intramuscular; Leukocyte Count; Lymphocyte Subsets; Lymphocytes; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Sizofiran; Survival Rate; T-Lymphocytes, Helper-Inducer | 1994 |
Effect of sizofiran on regional lymph nodes in patients with head and neck cancer.
Topics: Adjuvants, Immunologic; Antineoplastic Agents, Phytogenic; Head and Neck Neoplasms; Humans; Interleukin-2; Killer Cells, Lymphokine-Activated; Lymph Nodes; Sizofiran | 1996 |